BALANCE SHEETS - USD ($) $ in Thousands |
Dec. 31, 2015 |
Dec. 31, 2014 |
|---|---|---|
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $ 8,560 | $ 8,722 |
| Investment in BioCancell (Note 4) | 50 | 85 |
| Other current assets | 123 | 25 |
| Total current assets | 8,733 | 8,832 |
| Property and equipment, net | 67 | 88 |
| Total assets | 8,800 | 8,920 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| CURRENT LIABILITIES (Note 10a) | 226 | 184 |
| Total current liabilities | $ 226 | $ 184 |
| SHAREHOLDERS' EQUITY (Note 7): | ||
| Share capital - Ordinary shares no par value - Authorized: 16,666,667 shares at December 31, 2014 and 2015; Issued: 10,345,912 and 11,325,912 at December 31, 2014 and 2015 respectively; Outstanding: 8,898,861 and 9,878,861 at December 31, 2014 and 2015 respectively. | ||
| Additional paid-in capital | $ 147,444 | $ 146,721 |
| Treasury shares, at cost, 1,447,051 Ordinary shares at December 31, 2014 and 2015 | (1,065) | (1,065) |
| Accumulated deficit | (137,805) | (136,920) |
| Total shareholders' equity | 8,574 | 8,736 |
| Total liabilities and shareholders' equity | $ 8,800 | $ 8,920 |